RO130965A8 - Production and use of customized hyperimmune egg () in psoriasis treatment - Google Patents

Production and use of customized hyperimmune egg () in psoriasis treatment

Info

Publication number
RO130965A8
RO130965A8 ROA201500735A RO201500735A RO130965A8 RO 130965 A8 RO130965 A8 RO 130965A8 RO A201500735 A ROA201500735 A RO A201500735A RO 201500735 A RO201500735 A RO 201500735A RO 130965 A8 RO130965 A8 RO 130965A8
Authority
RO
Romania
Prior art keywords
customized
eggs
production
egg
hens
Prior art date
Application number
ROA201500735A
Other languages
Romanian (ro)
Other versions
RO130965A0 (en
Inventor
Constantin Chiurciu
Viorica Chiurciu
Lucica Sima
Iuliana Mihai
Ionel-Victor Pătraşcu
Original Assignee
Romvac Company S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romvac Company S.A. filed Critical Romvac Company S.A.
Priority to ROA201500735A priority Critical patent/RO130965A8/en
Priority to PCT/RO2016/000002 priority patent/WO2017065626A1/en
Priority to MA042973A priority patent/MA42973A/en
Priority to EP16716713.9A priority patent/EP3362092A1/en
Publication of RO130965A0 publication Critical patent/RO130965A0/en
Publication of RO130965A8 publication Critical patent/RO130965A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Abstract

The invention relates to a process for obtaining hyperimmune eggs and immunoglobulins from eggs from immunized hens, used for psoriasis treatment. According to the invention, the process consists in sampling, from skin lesions of a patient with psoriasis, a pathogenic material from which an immunogen is prepared to be administered to conventional laying hens, and afterwards, from the eggs of the serologically responsive hens, specific immunoglobulins are prepared to be then conditioned, together with the customized hyperimmune egg, for use as egg, liquid, spray, gel, cachets, compressed tablets or lyophilized or atomized yolk.
ROA201500735A 2015-10-16 2015-10-16 Production and use of customized hyperimmune egg () in psoriasis treatment RO130965A8 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ROA201500735A RO130965A8 (en) 2015-10-16 2015-10-16 Production and use of customized hyperimmune egg () in psoriasis treatment
PCT/RO2016/000002 WO2017065626A1 (en) 2015-10-16 2016-01-08 Manufacture and use of personalized hyperimmune egg in psoriasis treatment
MA042973A MA42973A (en) 2015-10-16 2016-01-08 MANUFACTURE AND USE OF PERSONALIZED HYPERIMMUNITY UF IN THE TREATMENT OF PSORIASIS
EP16716713.9A EP3362092A1 (en) 2015-10-16 2016-01-08 Manufacture and use of personalized hyperimmune egg in psoriasis treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ROA201500735A RO130965A8 (en) 2015-10-16 2015-10-16 Production and use of customized hyperimmune egg () in psoriasis treatment

Publications (2)

Publication Number Publication Date
RO130965A0 RO130965A0 (en) 2016-03-30
RO130965A8 true RO130965A8 (en) 2017-06-30

Family

ID=55754390

Family Applications (1)

Application Number Title Priority Date Filing Date
ROA201500735A RO130965A8 (en) 2015-10-16 2015-10-16 Production and use of customized hyperimmune egg () in psoriasis treatment

Country Status (4)

Country Link
EP (1) EP3362092A1 (en)
MA (1) MA42973A (en)
RO (1) RO130965A8 (en)
WO (1) WO2017065626A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO132299A3 (en) * 2017-06-06 2018-12-28 Fântână Raul Sorin Composition and method for preparing and evaluating a complex immunogen named i-spga meant to produce immunologically active proteins
US11319382B1 (en) 2021-06-28 2022-05-03 King Abdulaziz University Methods for producing and using IgY antibodies targeting the middle east respiratory syndrome coronavirus spike protein to treat or prevent MERS-CoV infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1068524C (en) * 1997-06-23 2001-07-18 叶庆炜 Process for preparing medicine for curing intractable psoriasis
CA2317813A1 (en) * 1998-01-19 1999-07-22 Sandra G. Fitzpatrick-Mcelligott Composition and method for treatment and prevention of arthritis and/or autoimmune diseases
WO2000029444A1 (en) * 1998-11-16 2000-05-25 Genway Biotech, Inc. Generation of antibodies using polynucleotide vaccination in avian species
DK2061510T3 (en) * 2006-08-31 2016-09-05 A C N 135 493 391 Pty Ltd As Trustee For Conca Unit Trust Treatment and / or prevention of Barrett's esophagus using anti-EphB4 antibody-containing compositions
US20100233162A1 (en) * 2007-08-30 2010-09-16 Bengt Agerup LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS
JP5439127B2 (en) * 2009-11-13 2014-03-12 株式会社さいわいメディカル Treatment for psoriasis or atopic dermatitis
RO129645B1 (en) * 2014-02-25 2022-05-30 Romvac Company S.A. Process for obtaining and using hen immunoglobulins (igy)
RO130213A8 (en) * 2014-10-29 2017-06-30 Romvac Company S.A. Production and use of hyperimmune egg - pc2

Also Published As

Publication number Publication date
WO2017065626A1 (en) 2017-04-20
MA42973A (en) 2018-08-22
EP3362092A1 (en) 2018-08-22
RO130965A0 (en) 2016-03-30

Similar Documents

Publication Publication Date Title
CO2018004321A2 (en) Antibody that neutralizes the human syncytial respiratory virus
ZA201904725B (en) Personalised immunogenic peptide identification platform
GEP20217326B (en) Constructs having a sirp-alpha domain or variant thereof
PT3377637T (en) Compositions and methods for the treatment of wounds, disorders, and diseases of the skin
BR112016015140A2 (en) tandem-fab immunoglobulin and its uses
GT201200318A (en) ANTIBODIES TO GDF8 HUMAN
PH12017500032A1 (en) Improved a� protofibril binding antibodies
JOP20170004B1 (en) ANTl-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
EA201791199A1 (en) METHOD OF TREATMENT OF ALZHEIMER'S DISEASE
MX2022009155A (en) Novel polymeric hgh prodrugs.
EP3576758A4 (en) Generation of human allergen-and helminth-specific ige monoclonal antibodies for diagnostic and therapeutic use
MX2022002635A (en) Angiopoietin-like 4 antibodies and methods of use.
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
CO2020000260A2 (en) Chimeric antibodies for the treatment of amyloid deposition diseases
MX2018009499A (en) Egfl6 specific monoclonal antibodies and methods of their use.
RO130965A8 (en) Production and use of customized hyperimmune egg () in psoriasis treatment
WO2018060528A3 (en) Therapeutic protein
MX2017001433A (en) Microscale bioprocessing system and method for protein manufacturing from human blood.
EA201500765A1 (en) METHODS OF TREATING CARDIOVASCULAR DISEASES
BR112018008769A2 (en) pharmaceutical formulations, reconstituted and lyophilized aqueous liquid formulations, syringe, method of manufacturing a pharmaceutical formulation, method for treating a disease and use of a reconstructed formulation
HUP1800041A2 (en) Process for the preparation of plant protein coagulum
MX2020009877A (en) Myotoxin-neutralizing peptides.
WO2016094341A8 (en) Triple combination therapy, comprising ganetespib, a taxane and an antibody, for use in the treatment of her2 positive breast cancer
GB201803563D0 (en) Antibodies and pharmaceutical compositions thereof for the treatment of autoimmune skin diseases
IT201600125172A1 (en) PLANT FOR THE CRYOGENIC TREATMENT OF THE HUMAN BODY